NOVOPEN Echo Plus Insulin Pen

Product Information

Novo Nordisk are delighted to announce the launch of NovoPen® 6 and NovoPen Echo® Plus in Ireland – smart insulin pens that offer digital connectivity for people with diabetes. Beyond reusable pens, which are more popular outside the US, Novo Nordisk also announced that connectivity for disposable pens is coming “later in 2019.” This feature will capture insulin doses through a Bluetooth-enabled smart device that is attached to the widely used disposable FlexTouch pen. The attachment will transmit the insulin dose, time of dose, and the type of insulin being injected to a phone app (an important safety precaution to avoid mix-ups). Novo Nordisk has not shared any pictures, so we’re not sure if it will include a screen and what apps it will communicate with. Still, it is exciting that Novo Nordisk will have smart connectivity for both reusable and disposable insulin pens! New Partnerships When your pancreas is working properly it makes small amounts of insulin all the time and releases more insulin when your blood glucose levels increase after eating. When you have diabetes, your body does not make enough insulin or the insulin it makes does not work properly.

NovoPen®6 or NovoPen Echo® Plus Your guide to using NovoPen®6 or NovoPen Echo® Plus

Visit www.diabeteswhatsnext.ie for more information on living with diabetes and NovoPen ® 6 and NovoPen Echo ® Plus smart insulin pens. Diabetes Novo Nordisk NovoPen NovoPen Ech Toujeo comes as pre-filled pens. Toujeo contains 300 units of insulin per 1ml of liquid which is 3 times more concentrated than the other brands.

We spoke to two members of the diabetes community to understand their experiences with smart insulin pens and explore the impact that widespread use of these pens could have on diabetes teams as well as people with diabetes. What is a smart insulin pen? NovoPen ® 6 and NovoPen Echo ® Plus automatically record accurate and reliable insulin dosing information, giving people insight into their own data, and enabling more productive conversations with their healthcare provider, that can lead to better health outcomes. Diabetes is a difficult condition to manage and the number of people living with it is on the rise. When diabetes is poorly controlled and not managed properly it can lead to health complications for people. They come in different brands and are used with different types of insulin pen, but they all work in a similar way. Novo Nordisk has signed collaboration agreements with Glooko, Roche and DexCom to support the future integration of its NovoPen 6 and NovoPen Echo Plus insulin pens with digital health solutions.

Smart insulin pens: How they work, and your experiences of

The devices have a dose memory display which shows the amount of time that has passed since the last dose, and they can show a person when a dose has been missed. Roche expects Novo Nordisk insulin pen data will sync to the mySugr app and Accu-Chek SmartPix software. For mySugr Bundle users, coaches will now get injection history alongside other diabetes data. Results from an observational study indicate that using NovoPen 6 to administer their insulin could give people living with type 1 diabetes close to two extra hours of improved glucose levels (measured as HbA 1c 3.9 – 10.0 mmol/L) per day, with a reduction in time spent in hyperglycaemia (measured as HbA 1c >10 mmol/L) and level 2 hypoglycaemia (measured as HbA 1c <3.0 mmol/L). A further analysis looking at missed bolus doses (insulin that is specifically taken at mealtimes) indicated that NovoPen 6 decreased the average daily number of missed doses by 43% (p=0.002) by the end of the study.Pinder Sahota, General Manager, Novo Nordisk UK, said: “We believe digital innovation of devices and treatments has the potential to transform people’s lives and help alleviate the daily burden of living with diabetes.